SECTION-I: NANOMEDICINE IN NEURODEGENERATIVE DISORDERS
Ch1 - Fundamentals of Brain-Barrier Anatomy and Global Functions
Yasser Mecheri, Soundous Malak Behloul
Ch2 - Blood Brain Barrier in Neurodegenrative Disorders
Adejoke Elizabeth Memudu, Michael Oluwatosin Gabriel
Ch3 - Neurodegenerative Disorders, available therapies, and their limitations
Mohamed Zaki , Eman E. Mohamed , Osama M. Ahmed
Ch4 - Challenges in brain targeting and mechanism of drug transfer across BBB
Ahmad Kodous, Priya Ramanathan, Arunagiri Kuha Deva Magendhra Rao, Gamal Abdel Nasser Atia
Ch5 - Introduction to Nanomedicine, Nanotechnology and Nanopharmaceuticals
Abdullah M. M. Elbadry, Hend H. Mohamed
Ch6 - Regulations and Ethics of Nanomedicine and Public acceptance
Nada Abdel-Monaem
Ch7 - Safety of Nanoparticles in Medicine
Mona Mohammed Abd elHakeem khalifa
Ch8 - Enhancing Brain Drug Delivery with Lipid Nanocarriers for Bioactive Compounds
Shivakumar M Methri, Sivakumar Manickam, V. Ravichandiran, Subramanian Natesan
Ch9 - Blood brain Barrier disruption and Nanomedicine in Neurodegenerative disorders
Adejoke Elizabeth Memudu, Michael Oluwatosin Gabriel, Grace Temitope Akingbade, Happiness Ochi Inyang, Omamuyovwi Meashack Ijomone
Ch10 - Worldwide Development and Commercialization of Nanomedicine
Hadeer N. Atalah, Esraa M. Qansuwa
SECTION-II: NANOPARTICLES AND NEURODEGENERATIVE DISORDERS
Ch11 - Introduction to nanoparticles as a potential carrier for brain targeting in Neurodegenerative Disorders
Adejoke Elizabeth Memudu, Michael Oluwatosin Gabriel, Victor Ebube Anadu, Olayemi Kafilat Ijomone, Omamuyovwi Meashack Ijomone
Ch12 - Application of polymeric nanoparticles in brain targeting
Moshera Samy
Ch13 - Lipid-based Nanocarriers for Brain Delivery of Bio-actives in the Treatment of Neurodegenerative Disorders
Khaled M. Kotb, Mohamed N. Sharafeldin, Hamsa Hassan, Achouak BOUTALBI, Ahmed Yahya, Haseen Fatima Niazi, Nouran A. Taha, Islam Omar, Amgad E. Salem
Ch14 - Autophagy and extracellular nanovesicles communication and their therapeutic application in neurodegenerative diseases.
Mohamed Abdelkader, Noha AboQuella
Ch15 - Mesoporous silica nanoparticles as promising carriers for brain delivery
Sudarshan Naidu Chilamakuri, Sivakumar Manickam, Rajukumar Malayandi Ravichandiran Velayutham, Subramanian Natesan
Ch16 - Potential of dendrimers as a nanocarrier for brain drug delivery
Arab Iram Saba Gaus Mohammed, Victor Hmingthansanga, Sivakumar Manickam, V. Ravichandiran, Subramanian Natesan
Ch17 - Surface active ligands for brain targeting
Mariam Zewail, Heba Abd-El-Azim
Ch18 - Nanocarriers for brain delivery: Safety, Stability concerns, and regulatory aspects
Asmaa Ashraf, Mohamed Dahab, Rahma Soliman
Ch19 - Advancements of nanocarriers for brain targeting and limitations in clinical translation
Nermeen Z. Abuelezz, Fayza Eid Nasr, Maria-Salud Garcia-Ayllon, Javier Saez-Valero
Ch20 - Toward Applicability of Exosomal-ncRNA Precision vs Nanoparticles to the Brain
Nadia M. Hamdy, Emad B. Basalious, Mona G. El-Sisi, Rana A. Youness, Ahmed S. Sultan
Ch21 - Current advancements of nanocarriers for neurodegenerative disorders linked to toxoplasmosis
Mohamed Y. Zaky, Nahed S. Lamloum
Ch22 - Toward Nano-drugs Precision for Neurodegenerative disease(s) or Glioma
Nadia M. Hamdy, Emad B. Basalious, Al-Aliaa Sallam, Fatma H. Shaker, Sujay Paul, Shih-Min Hsia, Mai M. Anwar
